Coronado Aesthetics LLC

Coronado Aesthetics LLC is a physician-guided aesthetic medical technology company specializing in microparticle-based acne treatments. The company acquired and markets Sebacia® AcneIQ™, an FDA-cleared in-office acne treatment that combines laser energy with topically delivered gold microparticles to selectively target sebaceous follicles. The treatment protocol consists of three sessions delivered over two weeks, with results reportedly lasting up to two years. The system is drug-free and requires no systemic medications such as Accutane, making it suitable for patients with moderate to severe acne who may be contraindicated for or seeking alternatives to pharmaceutical acne management. Coronado Aesthetics operates a network of qualified aesthetic and dermatology practices across the United States through their practice finder system, indicating a B2B distribution model targeting medical aesthetics clinics and dermatology offices. The company's Chief Medical Officer is Kouros Azar, MD. The product includes the Sebacia® AcneIQ™ Massager device and treatment vials (gold microparticle suspension) supplied in patient kits. Clinical validation is supported by peer-reviewed research published in the Journal of Investigative Dermatology and Practical Dermatology. The technology is based on selective photothermolysis principles applied to sebaceous follicles.